Pharmaceutical compositions

A package comprising at least one oral dosage form comprising oxcarbazepine in finely ground form having a median particle size of approximately 2 to 12 microns and having a maximum residue on a 40 micron sieve of up to 5%, for administration to a subject according to a method of treatment which provides that the dosage form is to be administered optionally in the fed or fasted state.

A method of treatment for reducing fed versus fasted state intra-subject variability of bioavailability levels of oxcarbazepine during oral oxcarbazepine therapy comprising administering an oral dosage form comprising oxcarbazepine in finely ground form having a median particle size of approximately 2 to 12 microns and having a maximum residue on a 40 micron sieve of up to 5%, according to a method of treatment which provides that the dosage form is to be administered optionally in the fed or fasted state.

An oral dosage form comprising oxcarbazepine for administration to a patient optionally in the fed or fasted state for the treatment of seizures or convulsions.

An oral dosage form comprising oxcarbazepine in finely ground form having a median particle size of approximately 2 to 12 microns and having a maximum residue on a 40 micron sieve of up to 5% for administration to a patient in the fasted state for the treatment of seizures or convulsions.

(canceled)